G-CSF Administration Is Associated with Worse Treatment Response and Survival after CAR T-Cell TherapyPoorva Bindal, Jon Arnason, Michael Leukam et al.|Blood|2022Cited by 4
High <scp>CD34</scp>‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortalityZachary M. Avigan, Richard L. Haspel, Ajoy Dias et al.|Transfusion|2024Cited by 2
Corticosteroids, Tocilizumab or Filgrastim Do Not Impact the Efficacy of CAR T-Cell Therapy with 4- 1BB Costimulatory DomainPoorva Bindal, Jon Arnason, Carolyn D. Alonso et al.|Transplantation and Cellular Therapy|2022Cited by 0